Dr.Casper Vroemen has served as IFF’s Senior Vice President Biosciences R&D andChief Research & Development Officer since September 2023. Dr. Vroemen isresponsible for furthering IFF’s R&D strategy acrossthe Company’s major markets in Health & Biosciences (Home and PersonalCare, Grain Processing, Animal Nutrition & Health, Food Biosciences, HealthSciences, Crop Biologicals, Designed Enzymatic Biomaterials), Scent, Taste. Hehas a strong track record in biotechnology and advances the Company’s effortsin innovation, technical development, external collaboration, and sustainability.He leads a global team of ~1,000 R&D professionals working at theintersection of science and creativity dedicated to creating innovative solutionsfor a better world.

Dr.Vroemen has been with the Company since 2004. Over the past two decades, he hasassumed roles of increasing responsibility in research and development inEurope and the US and has played a major role in establishing IFF as abioscience powerhouse. During his tenure, Dr. Vroemen oversaw IFF’sworld-leading positions in the protein engineering of industrial enzymes andthe development and scaleup of world-class enzyme manufacturing, contributingto the commercialization of many new technological advancements. He has drivenhundreds of products from concept to commercialization and authored numerouspatents. His career has been dedicated to the advancement of sustainable,innovative solutions across healthcare, food, consumer, and industrial markets. 

Dr.Vroemen holds a Master of Science in Molecular Life Sciences and a doctorate inMolecular Biology, both from Wageningen University in the Netherlands. He was avisiting scientist at Cold Spring Harbor Laboratory and UC riverside. He isbased in Palo Alto, CA.

‍